FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition for treating HIV infection as a solid dosage form containing at least one HIV protease inhibitor in a therapeutically effective amount specified in a group of nelfinavir, sacvinavir, tipranavir, darunavir, indinavir, ritonavir, lopinavir, palinavir or fosamprenavir, and pharmaceutically acceptable additives, differing by the fact that the pharmaceutically acceptable additives are presented by at least one water-soluble polymer in the amount of 0.4 to 49 wt % of the weight of the ready dosage form, one water-insoluble polymer in the amount of 0.39 to 28 wt % of the weight of the ready dosage form, surfactants, excipients to the weight of 100% of the ready dosage form, as well as a method of treating HIV infection.
EFFECT: composition possesses the improved technological properties and bioavailability as compared to a prototype drug.
13 cl, 7 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING HIV-INFECTION, METHOD FOR PREPARING AND METHOD OF USING | 2013 |
|
RU2543322C1 |
PHARMACEUTICAL COMPOSITION FOR HIV INFECTION TREATMENT | 2016 |
|
RU2619840C1 |
PHARMACEUTICAL COMPOSITION HAVING ANTI-HIV INFECTION ACTIVITY | 2017 |
|
RU2659693C1 |
SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURING ORAL ANTIRETROVIRAL THERAPEUTIC AGENT | 2020 |
|
RU2760129C1 |
NEW COMBINED PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT FOR TREATMENT OF CORONAVIRUS INFECTION | 2022 |
|
RU2806643C1 |
SOLID PHARMACEUTICAL COMPOSITION FOR MANUFACTURE OF ORAL THERAPEUTIC AGENT FOR PREVENTION AND/OR TREATMENT OF HIV INFECTION | 2021 |
|
RU2759544C1 |
PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
NEW ANTIRETROVIRAL COMBINATION | 2008 |
|
RU2508105C2 |
METHOD FOR APPLICATION OF COPOLYMER OF DIMETHYLAMINOETHYLMETHACRYLATE, BUTYLMETHACRYLATE AND METHYL METHACRYLATE TO INCREASE SOLUBILITY AND/OR BIOAVAILABILITY OF ANTIRETROVIRAL ACTIVE PHARMACEUTICAL SUBSTANCE IN MANUFACTURE OF SOLID DISPERSION ON GRANULAR CARRIER | 2020 |
|
RU2759547C1 |
COMPOSITION FOR PREVENTION AND / OR TREATMENT OF HIV INFECTION | 2017 |
|
RU2663466C1 |
Authors
Dates
2014-01-27—Published
2012-12-29—Filed